The global opioids market was valued at USD 5.4 billion in 2022, growing at a CAGR of 3.7% from 2023 to 2032. The market is expected to reach USD 7.7 billion by 2032. The opioid market is growing due to the increasing approval of opioid medications for treating severe pain caused by chronic diseases. Furthermore, the increasing cancer rate also increases the demand for opioid drugs, propelling the market's growth.
Medications that are used for the treatment of persistent and severe pain, such as chronic backaches and headaches, are opioids by patients experiencing severe pain associated with cancer or patients recovering from surgery or by children and adults injured while playing sports or severely injured in accidents or have fallen from great heights. Narcotics is the other name used for opioids. Usually, opioids of different strengths are prescribed by doctors after analyzing the patient and the circumstances, the situation, and the type and level of pain. Although some opioids are used for treating diarrhoea and cough, these medications are provided mainly by seeing the prescription only for treating moderate to severe pain caused by injuries. Some of the opioid drugs physicians prescribe include oxycodone, morphine, hydrocodone, codeine, methadone, fentanyl, and others. Some opioid drugs are used to manage severe pain caused in cancer patients and treat constant pain in patients suffering from chronic illness or terminal diseases.
Get an overview of this study by requesting a free sample
In August 2020, Olinvyk (oliceridine), an opioid medication indicated for short-term intravenous use in hospitals or other controlled clinical settings, such as during inpatient and outpatient procedures, was approved by the U.S. Food and Drug Administration (FDA) for sale by Trevena Inc.
In April 2021, the U.S. FDA approved morphine sulfate injection, an opioid analgesic for managing severe pain from different conditions.
In October 2021, Celecoxib and tramadol hydrochloride (Seglentis), a combination of non-steroidal anti-inflammatory and opioid agonists, were approved by the U.S. Food and Drug Administration for the treatment of people with acute pain.
Increasing geriatric population- Due to the high prevalence of comorbid disorders, the elderly population is at significant risk of developing chronic diseases like cancer, arthritis, and cardiovascular diseases. The elderly population increased from 1.0 million in 2020 to 1.4 million in 2021, according to the World Health Organisation (WHO). One of the reasons for the rise in the elderly population is declining fertility and death rates. The effects of chronic pain worsen with age and are most severe in persons 65 years of age and beyond. As a result, it is projected that there will be greater demand for opioid medications to treat chronic pain as the geriatric population grows. Thus, the rising geriatric population is expected to add impetus to the market's growth during the forecast period.
Side effects associated- There are several side effects of using opioid drugs without a prescription, which is expected to restrain the market's growth. Furthermore, the misuse of these drugs is also expected to hamper the market's growth. Around 0.5 million individuals died in 2021 as a result of drug abuse, according to the WHO.
Increase in the launch of new opioid medicines- Rising approval rates and the introduction of new opioid medications for treating patients with chronic pain are expected to provide growth opportunities for the market over the forecast period.
Stringent government regulations- According to the Millennium Health Signals report (2020), from March to May 2020, there was an increase in the non-prescribed use of fentanyl by 32.0%, methamphetamine by 20.0% and cocaine by 10.0%. Therefore, it is anticipated that the implementation of severe regulations on the use of opioids will challenge the market's growth over the forecast period.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the most significant global opioids market, with a 43% market revenue share in 2022.
North America dominates the opioids market and will likely maintain its dominance over the forecast period. The United States has the most significant market share in North America. The market for opioids in the North American region has been increasing owing to rising product approvals by the regulatory authorities in the region, such as U.S. Food and Drug Administration. Furthermore, there is an increase in medication approval to meet the region's unmet medical needs. For instance, Hikma Pharmaceuticals introduced Buprenorphine Hydrochloride Injection, a generic form of Buprenex, in the United States in May 2020. A pharmaceutical opioid called Buprenex treats individuals with moderate to severe pain. This injection aids in the treatment of severe pain. A 5mL solution of injection administered intravenously costs about USD 89.
North America Region Opioids Market Share in 2022 - 43%
Check the geographical analysis of this market by requesting a free sample
The product type segment is divided into methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone, and others. The oxycodone segment dominated the market, with a market share of around 24% in 2022.
The application segment is divided into pain management, cough treatment, and diarrhoea treatment. The pain management segment dominated the market, with a market share of around 39% in 2022. The increasing demand for opioids for pain management caused by severe illness propels the segment's growth. The sudden increase in the number of people experiencing chronic headaches, migraines, and backaches; those healing from surgery or dealing with excruciating pain brought on by cancer; and people hurt while participating in sports, in auto accidents, or in other mishaps increases the demand for opioids.
|Market Size||Revenue (USD Billion)|
|Market size value in 2022||USD 5.4 Billion|
|Market size value in 2032||USD 7.7 Billion|
|CAGR (2023 to 2032)||3.7%|
|Region||The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.|
|Segments||Product Type, Application|
As per The Brainy Insights, the size of the opioids market was valued at USD 5.4 billion in 2022 to USD 7.7 billion by 2032.
The global opioids market is growing at a CAGR of 3.7% during the forecast period 2023-2032.
North America emerged as the largest opioids market.
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Product Type
4.3.2. Market Attractiveness Analysis by Application
4.3.3. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2.1. Increasing geriatric population
5.3.1. Side effects associated
5.4.1. Increase in launch of new opioids medicines
5.5.1. Stringent government regulations
6. Global Opioids Market Analysis and Forecast, By Product Type
6.1. Segment Overview
7. Global Opioids Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Pain Management
7.3. Cough Treatment
7.4. Diarrhoea Treatment
8. Global Opioids Market Analysis and Forecast, By Regional Analysis
8.1. Segment Overview
8.2. North America
8.5. South America
8.6. Middle East and Africa
8.6.2. South Africa
9. Global Opioids Market-Competitive Landscape
9.2. Market Share of Key Players in Global Opioids Market
9.2.1. Global Company Market Share
9.2.2. North America Company Market Share
9.2.3. Europe Company Market Share
9.2.4. APAC Company Market Share
9.3. Competitive Situations and Trends
9.3.1. Product Launches and Developments
9.3.2. Partnerships, Collaborations, and Agreements
9.3.3. Mergers & Acquisitions
10. Company Profiles
10.1. AstraZeneca Plc.
10.1.1. Business Overview
10.1.2. Company Snapshot
10.1.3. Company Market Share Analysis
10.1.4. Company Product Portfolio
10.1.5. Recent Developments
10.1.6. SWOT Analysis
10.2. Johnson & Johnson, Inc.
10.2.1. Business Overview
10.2.2. Company Snapshot
10.2.3. Company Market Share Analysis
10.2.4. Company Product Portfolio
10.2.5. Recent Developments
10.2.6. SWOT Analysis
10.3. Mallinckrodt Pharmaceuticals
10.3.1. Business Overview
10.3.2. Company Snapshot
10.3.3. Company Market Share Analysis
10.3.4. Company Product Portfolio
10.3.5. Recent Developments
10.3.6. SWOT Analysis
10.4. Pfizer, Inc.
10.4.1. Business Overview
10.4.2. Company Snapshot
10.4.3. Company Market Share Analysis
10.4.4. Company Product Portfolio
10.4.5. Recent Developments
10.4.6. SWOT Analysis
10.5. Teva Pharmaceuticals
10.5.1. Business Overview
10.5.2. Company Snapshot
10.5.3. Company Market Share Analysis
10.5.4. Company Product Portfolio
10.5.5. Recent Developments
10.5.6. SWOT Analysis
10.6. Purdue Pharma LP
10.6.1. Business Overview
10.6.2. Company Snapshot
10.6.3. Company Market Share Analysis
10.6.4. Company Product Portfolio
10.6.5. Recent Developments
10.6.6. SWOT Analysis
10.7. C.H. Boehringer Sohn Ag and Ko. Kg
10.7.1. Business Overview
10.7.2. Company Snapshot
10.7.3. Company Market Share Analysis
10.7.4. Company Product Portfolio
10.7.5. Recent Developments
10.7.6. SWOT Analysis
10.8. Sanofi S.A.
10.8.1. Business Overview
10.8.2. Company Snapshot
10.8.3. Company Market Share Analysis
10.8.4. Company Product Portfolio
10.8.5. Recent Developments
10.8.6. SWOT Analysis
10.9. Endo Pharmaceuticals Inc.
10.9.1. Business Overview
10.9.2. Company Snapshot
10.9.3. Company Market Share Analysis
10.9.4. Company Product Portfolio
10.9.5. Recent Developments
10.9.6. SWOT Analysis
10.10. Sun Pharmaceuticals
10.10.1. Business Overview
10.10.2. Company Snapshot
10.10.3. Company Market Share Analysis
10.10.4. Company Product Portfolio
10.10.5. Recent Developments
10.10.6. SWOT Analysis
List of Table
1. Global Opioids Market, By Product Type, 2019-2032 (USD Billion)
2. Global Methadone, Opioids Market, By Region, 2019-2032 (USD Billion)
3. Global Codeine, Opioids Market, By Region, 2019-2032 (USD Billion)
4. Global Fentanyl, Opioids Market, By Region, 2019-2032 (USD Billion)
5. Global Oxycodone, Opioids Market, By Region, 2019-2032 (USD Billion)
6. Global Morphine, Opioids Market, By Region, 2019-2032 (USD Billion)
7. Global Hydrocodone, Opioids Market, By Region, 2019-2032 (USD Billion)
8. Global Others, Opioids Market, By Region, 2019-2032 (USD Billion)
9. Global Opioids Market, By Application, 2019-2032 (USD Billion)
10. Global Pain Management, Opioids Market, By Region, 2019-2032 (USD Billion)
11. Global Cough Treatment, Opioids Market, By Region, 2019-2032 (USD Billion)
12. Global Diarrhea Treatment, Opioids Market, By Region, 2019-2032 (USD Billion)
13. North America Opioids Market, By Product Type, 2019-2032 (USD Billion)
14. North America Opioids Market, By Application, 2019-2032 (USD Billion)
15. U.S. Opioids Market, By Product Type, 2019-2032 (USD Billion)
16. U.S. Opioids Market, By Application, 2019-2032 (USD Billion)
17. Canada Opioids Market, By Product Type, 2019-2032 (USD Billion)
18. Canada Opioids Market, By Application, 2019-2032 (USD Billion)
19. Mexico Opioids Market, By Product Type, 2019-2032 (USD Billion)
20. Mexico Opioids Market, By Application, 2019-2032 (USD Billion)
21. Europe Opioids Market, By Product Type, 2019-2032 (USD Billion)
22. Europe Opioids Market, By Application, 2019-2032 (USD Billion)
23. Germany Opioids Market, By Product Type, 2019-2032 (USD Billion)
24. Germany Opioids Market, By Application, 2019-2032 (USD Billion)
25. France Opioids Market, By Product Type, 2019-2032 (USD Billion)
26. France Opioids Market, By Application, 2019-2032 (USD Billion)
27. U.K. Opioids Market, By Product Type, 2019-2032 (USD Billion)
28. U.K. Opioids Market, By Application, 2019-2032 (USD Billion)
29. Italy Opioids Market, By Product Type, 2019-2032 (USD Billion)
30. Italy Opioids Market, By Application, 2019-2032 (USD Billion)
31. Spain Opioids Market, By Product Type, 2019-2032 (USD Billion)
32. Spain Opioids Market, By Application, 2019-2032 (USD Billion)
33. Asia Pacific Opioids Market, By Product Type, 2019-2032 (USD Billion)
34. Asia Pacific Opioids Market, By Application, 2019-2032 (USD Billion)
35. Japan Opioids Market, By Product Type, 2019-2032 (USD Billion)
36. Japan Opioids Market, By Application, 2019-2032 (USD Billion)
37. China Opioids Market, By Product Type, 2019-2032 (USD Billion)
38. China Opioids Market, By Application, 2019-2032 (USD Billion)
39. India Opioids Market, By Product Type, 2019-2032 (USD Billion)
40. India Opioids Market, By Application, 2019-2032 (USD Billion)
41. South America Opioids Market, By Product Type, 2019-2032 (USD Billion)
42. South America Opioids Market, By Application, 2019-2032 (USD Billion)
43. Brazil Opioids Market, By Product Type, 2019-2032 (USD Billion)
44. Brazil Opioids Market, By Application, 2019-2032 (USD Billion)
45. Middle East and Africa Opioids Market, By Product Type, 2019-2032 (USD Billion)
46. Middle East and Africa Opioids Market, By Application, 2019-2032 (USD Billion)
47. UAE Opioids Market, By Product Type, 2019-2032 (USD Billion)
48. UAE Opioids Market, By Application, 2019-2032 (USD Billion)
49. South Africa Opioids Market, By Product Type, 2019-2032 (USD Billion)
50. South Africa Opioids Market, By Application, 2019-2032 (USD Billion)
List of Figures
1. Global Opioids Market Segmentation
2. Global Opioids Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Opioids Market Attractiveness Analysis by Product Type
9. Global Opioids Market Attractiveness Analysis by Application
10. Global Opioids Market Attractiveness Analysis by Region
11. Global Opioids Market: Dynamics
12. Global Opioids Market Share by Product Type (2023 & 2032)
13. Global Opioids Market Share by Application (2023 & 2032)
14. Global Opioids Market Share by Regions (2023 & 2032)
15. Global Opioids Market Share by Company (2022)
This study forecasts global, regional, and country revenue from 2019 to 2032. The Brainy Insights has segmented the global opioids market based on the below-mentioned segments:
Global Opioids Market By Product Type:
Global Opioids Market By Application:
Global Opioids Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date